JNJ Q2 earnings beat expectations, sees $2.5B from COVID vaccine
Healthcare venture capital has already blown away 2020 records
Is JNJ near the end of its opioid liability hangover?
US approvals of high risk med devices down
*please scroll down for all the latest news*
